Univariate landmark analyses among patients alive at 8, 12, 16 and 24 weeks showed a trend towards better survival for responders compared with non-responders, but did not reach a significant level at any time (P values 0.78, 0.57, 0.23 and 0.12, respectively).
← all excerpts
Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications.
1
—
—